Rifampicin adsorption and release study using Santa Barbara amorphous-16 modified Al (SBA-16-Al) for a drug delivery system-Reference-Cited by-同舟云学术

Rifampicin adsorption and release study using Santa Barbara amorphous-16 modified Al (SBA-16-Al) for a drug delivery system

Published:2024 Issue:11 Volume:14 Page:7371-7382
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Prihatiningsih Maria Christina¹^ORCID,Pratama Chaidir²^ORCID,Kundari Noor Anis¹,Megasari Kartini¹,Ariyanti Dhita¹,Saputra Andri³^ORCID,Kusuma Hersandy Dayu⁴^ORCID,Astuti Puji¹

Affiliation:

1. Polytechnic Institute of Nuclear Technology, National Research and Innovation Agency (BRIN), Yogyakarta, Indonesia

2. Research Center for Radioisotope, Radiopharmaceutical, and Biodosimetry Technology, Research Organization of Nuclear Energy, National Research and Innovation Agency (BRIN), Indonesia

3. Department of Rubber and Plastic Processing Technology, Politeknik ATK Yogyakarta, Indonesia

4. Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Jl. Raya Bandung – Sumedang KM. 21 Jatinangor, Sumedang 45363, Indonesia

Abstract

In this study, the surface modification of Santa Barbara Amorphous-16 (SBA-16) with aluminum (SBA-16-Al) was carried out as a rifampicin matrix for the treatment of tuberculosis.

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/RA/D3RA08360H

Reference58 articles.

1. Bacillus Calmette-Guérin (BCG) vaccine: A global assessment of demand and supply balance

2. Tuberculosis treatment

3. Chemotherapy to Tuberculosis

4. Naturally Derived Carbon Dots In Situ Confined Self-Healing and Breathable Hydrogel Monolith for Anomalous Diffusion-Driven Phytomedicine Release